# Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients

> **NCT03285165** · PHASE2,PHASE3 · SUSPENDED · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** 0.2-0.7 mcg/kg/h dexmedetomedine infusion.
- **DRUG:** 10-70 mcg/kg/h propofol infusion.

## Key facts

- **NCT ID:** NCT03285165
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2017-09-14
- **Primary completion:** 2021-09-16
- **Final completion:** 2021-09-16
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** NO AVAILABLE FUND
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03285165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03285165, "Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03285165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*